Navigation Links
Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
Date:7/11/2013

Ponte Vedra Beach, Florida (PRWEB) July 11, 2013

This week's top news item on HealthEconomics.Com included the results from a Standard & Poor Rating Service report, reflecting agency concerns that Big Pharma’s current American pricing flexibility may diminish over the next few years. They suggest the reasons are due to the rapidly growing costs of Medicare and Social Security with the aging of the U.S. population, and public and private sector healthcare payers looking to control their medical expenses. The story summary can be viewed on HealthEconomics.Com, and was originally sourced from the Healthcare Payer News edition, dated June 28, 2013.

Another popular story from the HealthEconomics.Com newsletter was based on the results from the Organization for Economic Cooperation and Development (OECD) Health Data 2013 report, showing that health spending remained flat for OECD countries in 2011, but pharmaceutical spending experienced deep cuts during the same year. Only two countries, Israel and Japan, experienced an increase in health spending since 2009 compared with the period before, and United States health spending as a portion of the Gross Domestic Product remained stable at 17.7% from 2009 to 2011. The original OECD report was summarized in PharmaTimes Online on July 3, 2013.

A third most-popular story on HealthEconomics.Com was an article describing the explosive growth in the worldwide virtual conference market, estimated to grow at a compound annual growth rate of 56% between 2013 and 2018. The story explored the use of Virtual Trade Shows and Marketplaces for the health care managed markets arena and the use of a newly-launched service by HealthEconomics.Com, called HE-Xpo. HE-Xpo is uniquely positioned to address the educational and informational needs of payers, pharmaceutical industry
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. HealthEconomics.Com Launches a New Specialty Pharma Newsletter to Worldwide Community of Industry Insiders Within Specialty Pharmaceuticals
2. Ohr Pharmaceutical Achieves 50% Enrollment Milestone in Squalamine Eye Drop Phase II Clinical Trial
3. Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
4. iBio Pharmaceutical Technology Embraced by the Government of Brazil
5. Piedmont Pharmaceuticals Gains FDA Approval of Animal Health Soft Chew Pain Medication
6. Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
7. North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017
8. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
9. Frost & Sullivan Recognizes Sciformixs Continued Growth in the Increasingly Complex Pharmaceutical KPO Market
10. Auxilium Pharmaceuticals, Inc. To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
11. BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 18, 2014 ... nation’s leading specialty pharmacies, has an expanded team ... clinical pharmacy consultants for prescriber offices in their ... , “We have a variety of Regional ... example, those specializing in hepatitis C help prescribers ...
(Date:12/19/2014)... December 18, 2014 LayerBio is an ... and wound care. The National Eye Institute (NEI) at ... a Phase I SBIR grant to develop a drug-eluting ... the most common cause of vision loss in people ... worldwide. According to Dr. Ken Mandell, LayerBio’s Founder and ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 Reports from ... the United States suffer from one or more chronic ... or cancer. Medication can address some of these diseases, ... activities that many sufferers face. While implanted nerve stimulation ... stimulate the whole nerve, which can induce side effects. ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 In contrast ... of LEDs with various colors, Valoya uses proprietary LED ... This offers best possible uniformity which is critical in ... and high spectral accuracy throughout its lifetime which is ... LED tubes. , "The investment cost was clearly ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2
... CITY, Panama, May 21, 2012 International scientific ... to discuss the potential use of Oxitec,s genetically modified ... Fever in Panama. The independent forum was co-organised ... Institute for Health Studies and the University of Panama. This ...
...  Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that Dr. ... will be presenting at the Seventh Annual Neurotech ... http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) The title of ... Attractive Targets for Active and Passive Immunotherapy." His ...
... May 16, 2012  Sigma-Aldrich announced today that it has ... will mature on May 10, 2017.  The new facility ... scheduled to mature on December 11, 2012.  The $600 ... paper program and be used for general corporate purposes. ...
Cached Biology Technology:Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 2Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 3Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
(Date:11/18/2014)... The Parenteral Drug Association (PDA) today confirmed that ... and at least seven more will participate in the upcoming ... Hotel in Washington D.C. , Dec. 2-4. ... support from the regulatory agencies in the United ... our effort to help advance the use of metrics in ...
Breaking Biology News(10 mins):Inception Technologies to Release New Biometric Reader 2C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... part of their ongoing research on the physiologic factors that ... have identified a cell cycle transcriptional co-regulator TRIP-Br2 ... storage. This finding has the potential to lead to ... ahead of print by Nature Medicine . Transcriptional ...
... Many of the nation,s foremost authorities on cyber security ... Cyber Sciences Laboratory workshop. The event will feature 10 plenary ... Threat to National Security and What to do About it." ... talks and 20 research posters. Researchers from nine Department of ...
... Barbara, Calif.) While legions of medical researchers have ... and how mutations may affect human health, a group ... the metabolism of cells and their surrounding tissue, to ... approach, which includes computer modeling, can be applied to ...
Cached Biology News:Joslin researchers identify important factor in fat storage and energy metabolism 2January 2013 story tips from Oak Ridge National Laboratory 2UCSB researchers perform pioneering research on Type 2 diabetes 2UCSB researchers perform pioneering research on Type 2 diabetes 3